ARC Future Fellowships - Grant ID: FT0991986

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/FT0991986

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Targeting brain lipid homeostasis to treat Alzheimer's disease. Dementia affects approximately 250,000 people in Australia at an estimated cost (in 2002) of $6.6 billion per annum. The major cause of dementia (accounting for approximately 70% of all cases) is Alzheimer's disease (AD); a progressive neurodegenerative illness for which there is no curative or disease-stalling treatment. Due to increases in life expectancy, the incidence of AD is predicted to triple by 2050 unless disease-modifying treatments are developed. This research program will provide novel realistic pharmaceutical approaches to treat AD. Even if the onset of AD could be delayed by a few years the personal and financial benefits would be enormous. The potential for this research to generate commercially viable Australian intellectual property is also significant.

Funded Activity Details

Start Date: 01-01-2010

End Date: 31-12-2013

Funding Scheme: ARC Future Fellowships

Funding Amount: $788,800.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cellular Nervous System | Medical Biochemistry: Lipids | Neurosciences | Cell Neurochemistry

ANZSRC Socio-Economic Objective (SEO)

Nervous system and disorders | Health related to ageing | Treatments (e.g. chemicals, antibiotics) |

Other Keywords

Cell Neurochemistry | Cellular Nervous System | Health related to ageing | Medical Biochemistry: Lipids | Nervous system and disorders | Neurosciences | Treatments (e.g. chemicals, antibiotics)

Related Links